title: NICE recommends first drug through "managed access" model of the Cancer Drugs Fund.
authors.affiliation: London.
authors.forename: Susan
authors.initials: S
authors.lastname: Mayor
mesh_terms: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004739:England; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000191:economics / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D013222:State Medicine / Q000191:economics*; D007211:Indoles; D011743:Pyrimidines
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D000970:Antineoplastic Agents; D010879:Piperazines; C000596361:osimertinib; D007211:Indoles; D011743:Pyrimidines